The interest in establishing and interpreting lymphocyte function in the rheumatic diseases has continued since lymphocytes were shown to be the major cell type involved in immune reactions and since they have been shown to be directly involved in the production and maintenance of inflammatory synovitis in rheumatoid arthritis (RA) (Pearson et al., 1975) . Autoimmune diseases such as RA could result from an abnormality at 1 or more of several stages in an immune response or from a breakdown in the control of the immune system.
As well as the cellular and humoral aspects of the immune system being disturbed it is conceivable in autoimmune disease that the K cell, which is cytotoxic towards antibody-sensitised target cells, is involved in tissue damage. This cytotoxicity would be directed against any cell which carries the antigen against which autoantibody is directed.
Several investigations into the in-vitro reactivity of lymphocytes from patients with rheumatic diseases have been carried out, giving differing results: in mitogen-induced transformation (e.g., Lance and Knight, 1974; Lockshin et al., 1975; Rawson and Accepted for publication 5 January 1979 Correspondence to Professor R. N. M. MacSween, Pathology Department, Western Infirmary, Glasgow Gil 6NT. Huang, 1976) , and in antibody-dependent cytotoxicity (ADC) (e.g., Scheinberg and Cathcart, 1976; Isturiz et al., 1976) , although membrane marker studies of lymphocyte subpopulations have tended to show that the percentages in RA patients are normal (e.g., Sheldon et al., 1974; Brenner et al., 1975; Lockshin et al., 1975) . Some of the differences in results probably arise from the differences in laboratory techniques and in the methods of analysing data obtained.
One of the main technical problems leading to variability in results is the apparently large number of different functional subpopulations of lymphocytes which cannot easily be isolated for in-vitro tests. In the present study, therefore, in which peripheral blood lymphocytes were examined from several aspects, the results were analysed by 2 approaches. Firstly, the mean results for each test obtained in the various groups were compared. Secondly, correlations were sought between pairs of tests in an attempt to find relationships between different tests and also to see if there was any consistent abnormality in the lymphocytes in any of the diseases studied. The data also made possible an evaluation of the use of such tests in the study of lymphocytes in disease. 535 Patients Specimens were obtained from the following groups at the Centre for Rheumatic Diseases in Glasgow: (a) normal controls, comprising healthy staff members; (b) definite RA (Ropes et al., 1959) ; (c) ankylosing spondylitis (Bennett and Burch, 1968) ; (d) psoriatic arthritis (Moll and Wright, 1973) ; (e) Sjogren's syndrome with associated RA (Block et al., 1965) ; (f) sicca complex without associated RA (Whaley et al., 1973) .
In the further study of RA patients, the groups were made up as follows: (w) normal controls; (x) acutely presenting RA with disease duration of less than 1 year; (y) chronic RA in remission: (i) on chemotherapy, (ii) after withholding chemotherapy for 48 hours; (z) chronic RA with an exacerbation of the disease as judged by the examining physician, and confirmed by increased pain, morning stiffness, and joint tenderness.
No patient was tested who had received any form of therapy known to have or suspected of having an effect on immune responsiveness. This includes radiotherapy, recent surgery, or blood transfusions (Riddle and Berenbaum, 1967; Park et al., 1971) , steroids, immunosuppressive drugs, gold, D-penicillamine, or levamisole (Clements, 1973; Strong et al., 1973; Hurd and Guilano, 1975; Panush and Anthony, 1976) . The patients tested were either on no treatment or were receiving aspirin or related drugs, which have previously been shown not to affect lymphocyte subpopulations or mitogen responses (Froebel, unpublished results). The effect of drug removal on cytotoxicity was tested in a subgroup of RA patients.
Age-and sex-matched controls were tested on each day urith the patients in order to minimise the effect of day-to-day. experimental variation.
The numbers and various details of the patient and control groups are given in Tables 1 and 2 . (Miles Yeda) were diluted with sterile distilled water to give stock solutions containing 10, 100, and 1000 ,ug per ml. PWM (Gibco) was reconstituted with 10 ml of sterile distilled water, and stock solutions were made containing 1 %, 10%, and 100% of the original standard solutions.
Cultures were set up in triplicate in tissue-culture grade, flat-bottomed microplates (Flow Laboratories). To 0*2 ml of lympgocyte suspension mitogen was added to give final concentrations of PHA from 0 2 to 50 ,ug per ml; of con A from 0 5 to 30 ptg per ml, and of PWM from 0.01% to 1 % of the standard solution. The microplates were incubated in a moist atmosphere of 5% CO2 in air at 370C for 3 days. Cell proliferation was measured by uptake of 14C-thymidine during the last 18 hours of culture. The cells were transferred on to glass fibre discs and washed with saline followed by 5% trichloracetic acid and methanol. When dry the discs were put into 10 ml of scintillation fluid (4 g per 1 'Scintimix' in toluene) and 14C-thymidine uptake was measured on a Packard Tricarb liquid scintillation counter. (SNE) were carried out by the methods described by Sandilands et al. (1976) . Briefly, lymphocytes were mixed with EA, SE, or SNE and pelleted by centrifugation. The EA rosettes were resuspended and fixed for 20 min in 1 500 glutaraldehyde. The SE and SNE rosette tubes were kept at 40C overnight before fixing. The cells were then stained with 0 * 5 % trypan blue, and from each tube 1 drop was placed on each of 2 microscope slides and examined under petroleum jelly sealed coverslips. At least 200 lymphocytes on each slide were counted, and the blinding of 2 or more EA or 3 or more SE or SNE was regarded as rosette formation. Each test was performed in duplicate, so that at least 800 lymphocytes per test were examined to calculate the percentage of rosette forming cells.
SURFACE IMMUNOGLOBULIN
Two million lymphocytes were resuspended in 0 1 ml of phosphate buffered saline (PBS) in 1 5 ml capacity centrifuge tubes. To these, 0-1 ml of a 1:20 dilution of fluorescein conjugated swine antihuman immunoglobulin (Nordic Laboratories) was added, and the tubes were incubated in the dark for 45 minutes at room temperature. The cells were then washed twice and resuspended in 2-3 drops of a 1:1 PBS-glycerol mixture. One drop was put on to a microscope slide and the cells were examined under a petroleum jelly sealed coverslip by incident blue light to identify the fluorescing lymphocytes and by transmitted white light and a dark ground condenser to identify the total cell population. Phagocytic monocytes were distinguished from lymphocytes by prior incubation of the cells with latex particles (Singh et al., 1974) . Two separate counts of at least 100 cells were made on each side to determine the percentage of lymphocytes bearing surface immunoglobulin (SIg).
ANALYSIS OF RESULTS
The results were analysed on IBM 360/65 and 370/ 168 computers by a system of prewritten programsthe Statistical Package for the Social Sciences' (SPSS) (Nie et al., 1975) .
Initially the distribution of the results of each test for each patient group was analysed. These approached a normal distribution except for the response of 0-2 ,ug/ml phytohaemagglutinin (PHA) in the sicca complex patients. With this 1 exception, therefore, the mean results for each patient group could be compared with the controls by means of Student's t test. The Mann-Whitney test was used to compare the 0-2 Fg/ml PHA results for the sicca complex patients.
In the follow-up study of RA subgroups the possible error introduced by doing a large number of Student's t tests was reduced by comparing the means of the results by analysis of variance, and in cases where the F value was statistically significant the specific difference were located by the methods of angular transformation and multiple comparisons (Armitage, 1971) .
Subsequently the data were analysed to look for associations between functional tests and lymphocyte subpopulations, that is, between individual lymphocyte subpopulations and (1) mitogen responsiveness and (2) ADC. Correlations were also sought between the in-vitro results, age, and serological indices. Because of the large number of correlation tests carried out, significant correlation coefficients between tests of lymphocyte function and a particular lymphocyte subpopulation were considered relevant only if they were consistent for several of the concentrations at which the functional test was carried out.
Results
The results of the various tests are shown graphically-the numerical data are available on request.
MITOGEN-INDUCED TRANSFORMATION
The results of the PHA, con A, and PWM stimulated cultures are shown in Fig. 1 . The seropositive RA group showed slightly reduced responses, particularly to low concentrations of PHA. The differences were just significant at the 0 *2 ,g per ml and 05 ,ug per ml doses of PHA (P=0047 and 0o 048 respectively).
The Sjogren's syndrome group had a significantly reduced response to 0 5 ,g per ml PHA (P= 0005) and to 0 1 % PWM (P=0-029). The sicca complex group had a reduced response to PHA which was significant at the 0 2 ,ug per ml (P<0 02) and at the 0 5 Vg per ml concentrations (P<0 001).
In the patients with seronegative arthritis there were no significant differences between the means of the ankylosing spondylitis and control groups with any of the 3 mitogens. The psoriatic arthritis group concentration (P=0-012). The response to Con A of the psoriatic arthritis was significantly reduced at the 2 highest concentrations tested, (P=0 011 at 10 jig per ml and P=0 004 at 30 ,ug per ml con A).
ANTIBODY-DEPENDENT CYTOTOXICITY
The results of the first study are shown in Fig. 2 as the spontaneous and specific cytotoxicity using 1 x 104 Chang cells at the 3 lymphocyte concentrations tested. The seropositive RA patients showed a very significant reduction in specific cytotoxicity, the significance levels being P=0 019, 0 010, and 0 001 for the 1 x 105, 3 x 105, and 1 x 106 per ml lymphocyte concentrations respectively.
In the seronegative patients the ankylosing spondylitis group showed a significantly reduced level of specific cytotoxicity compared with the controls at both the 3 x 105 and 1 x 106 per ml lymphocyte concentrations (P=0-026 and 0 007 respectively).
The results of the follow-up study are shown in Fig. 3 . In the group of RA patients who were experiencing an exacerbation of their disease there was a significant reduction in both specific and total cytotoxicity levels at the 1 x 106 lymphocytes per ml Although in the initial study the RA patients had a lower mean percentage of EA rosette-forming lymphocytes than the controls (14-3% ± 1 5 % (SEM) and 19.0% ± 1 -2% respectively P=0 046), the follow-up study did not confirm the difference. The results of the SE and SNE rosette tests (Fig. 5) showed no significant differences between any of the groups.
SURFACE IMMUNOGLOBULIN
The results are shown in Fig. 6 . In the initial study, the Sj6gren's syndrome group had a significantly higher mean percentage of SIg-bearing lymphocytes than the controls (16* 8 % ± 2 -8 % SEM) and 10 * 3 % i1 0 % respectively, P =0 01 1). The sicca complex group had a mean percentage of SIg-bearing cells (143 % ± 1 *7 %) which was intermediate between the RA and the RA plus Sjogren's syndrome results. In the subsequent study the mean percentage was significantly raised in the group of RA patients in remission (19 0 ± 3 6 (SEM); the control mean in this study was 12*1 + 1-1, P<0 .0S). Although there was a slight increase Tables 3 and 4 . In the first study only the data from the control group were used for the correlation tests. This was a precaution taken in case, in a disease group, an abnormality might occur in one test but not in another related test, for instance, if a particular function was abnormal although the lymphocyte subpopulations were normal. On examination the results were found to be similar irrespective ofwhether the control group data alone or the pooled data from all the groups were analysed. In the followup study, therefore, in which the numbers in each Table 3 Correlations betweeni the lymphocyte responses to mitogens and (1) subpopulations and (2) group were small, the data were pooled for the correlation analysis.
The first study showed a slight but consistently positive association between the transformation results with each mitogen and the percentage of SE rosettes, and a corresponding negative association between the PHA results and the percentage of EA rosettes (Table 3) . The results also revealed a slight but consistent negative correlation between age and the transformation response to all three mitogens (Table 3 ). The cytotoxicity results correlated with the percentage of EA rosettes, and to a less extent (that is with low r values) with the percentage of Slgbearing cells (Table 4) .
In the follow-up study still higher correlation coefficients, which were more highly significant, were shown between the cytotoxicity and EA rosette results (Table 4) . No associations could be shown between haematological or serological indices and either the cytotoxicity or the lymphocyte subpopulation results (data not shown).
Discussion
The abnormal responses in patients in the tests of lymphocyte function reported above have nearly all tended to be in the direction of a reduced response. The problem of such in-vitro tests, however, is in knowing precisely which of the functional subpopulations of lymphocytes a particular test is measuring. Cellular (T cell mediated) immune reactions are being seen increasingly to be controlled by interactions between subpopulations of T cellsprimarily as a balance between helper and suppressor T cells (Allison et al., 1971; Dutton, 1975; Mitsuoka et al., 1976) . So although lymphocyte responses to PHA and con A have been widely used as an index of T cell function (Greaves et al., 1974; Campbell et al., 1973; MacSween et al., 1973; Mellstadt and Holm, 1973 ) the activities of these mitogens are now being described increasingly in terms of T cell subpopulations (Hubert et al., 1976; Tse and Dutton, 1977) . The reduced responses by RA patients, Sjogren's syndrome and sicca complex patients to low doses of PHA, but their normal responses to con A may mean that these patients are defective in a particular subpopulation of T cells or that their cells require a higher concentration of PHA to be 'switched on'. So too the abnormality in psoriatic arthritis (this group had reduced responses to high doses of both PHA and con A) may be in a T cell subpopulation, that, is, both PHA and con A responsive. Conceivably, reduced responses to non specific mitogens may be a result of an ongoing immune responses being mounted against some, as yet unknown, disease associated antigen.
The numbers of T cells, measured by the SE and SNE rosette tests, were within the normal range for all the patient groups tested. This finding supports the view that a numerically small subpopulation of T cells is sufficient to cause abnormal functional responses. The statistically significant but low correlation coefficient obtained between PHA and con A induced proliferation, and the percentage of SE (but not SNE) rosettes, shows that, while there is a positive relationship between these tests, factors other than merely the number of SE rosette-forming cells determine the extent of mitogen induced proliferation.
Patients with RA and to a less extent those with ankylosing spondylitis also showed diminished ADC against antibody sensitised Chang target cells. This finding was of particular interest in RA, since in patients with rheumatoid factor all the components required for an ADC reaction are present, and the question arises whether K cells mediate damage against immunoglobulin-bearing autologous cells. Our study cannot answer this question, but the follow-up study of subgroups of RA patients has shown that K cell activity is reduced, particularly in RA patients who are experiencing an exacerbation of their disease. This finding is at variance with some other studies of ADC in RA, which show either normal (Diaz-Jouanen et al., 1976; Scheinberg and Cathcart, 1976) or increased (Sany et al., 1977) activity in patients. These groups, however, used red blood cells as targets, and there is some evidence to suggest that different effector cells may be involved in killing these targets as opposed to metabolically active Chang cells (Scornik et al., 1974; Kovithavongs et al., 1975; Sanderson and Taylor, 1976) . However, Isturiz et al., (1976) have reported reduced ADC against red blood cells in RA and McGill and Twinn (1977) , also using red cells, found retrospectively that there was an inverse correlation between disease activity and K cell activity. The study of McGill and Twinn, together with our own, shows the need to use well-defined groups of patients for this type of investigation. Barnett and MacLennan (1968) reported that sera from some RA patients inhibited ADC probably via the binding of immune complexes to the Fc receptors on the K cell. These complexes would need to bind particularly avidly to survive the 3 washes given during lymphocyte preparation, but this explanation is in keeping with the view that the K cell belongs to a small subpopulation of Fc receptor-bearing cells with particularly avid binding receptors (Revillard et al., 1975; Sany et al., 1976) . Whether reduced K cell activity is a byproduct of an exacerbation of disease, or whether the inhibition of K cells by immune complexes leads to the exacerbation, is an intriguing question which still needs to be answered.
The correlation tests between the cytotoxicity results and the lymphocyte subpopulation tests confirm the relationship between cytotoxicity and the EA rosette-forming cell shown by several authors (e.g., De Bracco et al., 1976; Hersey et al., 1976; Sandilands et al., 1976) . However, the EA rosette test was not a sufficiently accurate measure of K cell activity to mirror the reduced cytotoxicity in the RA subgroup.
We cannot explain the increase in SIg-positive cells in the patients with Sjogren's syndrome and those with 'RA in remission'. Talal et al. (1974) obtained similar results in Sjbgren's syndrome and attributed these to the.binding of immune complexes to the lymphocyte membrane. Our results do not accord with this explanation, however, since immune complexes would be expected to inhibit ADC, and this was normal in these patients.
In conclusion, the results presented here show a generally reduced immunological responsiveness in RA by in-vitro tests, particularly, in patients in whom the disease is active and of long standing. The methods used, however, were unable to implicate a particular lymphocyte subpopulation. Our understanding of the immunological abnormalities in RA and other rheumatic diseases will become clearer as the functional subpopulations and their interdependence are characterised in greater detail. Future studies of immunological responses in the rheumatoid diseases will need to focus on specific effects mediated by defined subgroups or clones of reactive cells. 
